If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.


Biological Chemistry

Redirecting Amyloid Fibril Growth

A polymer-peptide conjugate causes amyloid-ß peptide to assemble into discrete nanostructures instead of fibrils

by Journal News and Community
April 21, 2014 | A version of this story appeared in Volume 92, Issue 16

Synthetic macromolecules can redirect the aggregation of amyloid-β (Aβ), the peptide associated with brain plaques in Alzheimer’s disease, from microscale fibrils to spherical nanostructures, chemists report (J. Am. Chem. Soc. 2014, DOI: 10.1021/ja501102f). The findings could help illuminate how amyloid fibrils grow, as well as suggest new therapeutic strategies for the disease, the researchers say. Jeffrey S. Moore and colleagues at the University of Illinois, Urbana-Champaign, wanted to disrupt amyloid assembly by interfering with weak interactions between Aβ monomers. Their inhibitors consisted of a copolymer backbone decorated with 21 copies of a peptide that binds to a region of Aβ that interacts with other monomers. When the team added the polymer-peptide conjugate to an equal amount of Aβ peptide, the conjugate completely suppressed fibril formation. The chemists were surprised to find that instead Aβ formed nearly spherical structures about 30 nm in diameter. The researchers are currently investigating the composition of these nanostructures. Understanding their structures and how they form may suggest new ways to prevent or disrupt amyloid aggregation, Moore says.


This article has been sent to the following recipient:

Chemistry matters. Join us to get the news you need.